International Market ExpansionThe recent endorsement by EU member states on the regulation of plants obtained by New Genomic Techniques could eventually translate into an expanded market opportunity for Cibus in Europe.
Regulatory ApprovalThe USDA-APHIS determined that the plants developed using Cibus’ RTDS gene editing technology do not fall under the definition of a 'regulated article' and therefore won’t be subject to regulations.
Revenue GrowthCibus' revenues increased by 135% year-over-year, mainly through collaboration agreements and sales related to developing a palm oil alternative.